Cardiac Risks of Diabetes Drugs a Focus at EASD
BARCELONA (MedPage Today) -- A major focus of the upcoming meeting of the European Association for the Study of Diabetes here will be the risks and benefits of the incretin-based therapies, according to the chair of the program committee.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Incretin Therapy | Study